NPs Basic Information

Name
Palmarumycin B5
Molecular Formula C20H18O8
IUPAC Name*
(3'S,4'R,6'S,7'R,8'aR)-3',4',6',7',8'a-pentahydroxyspiro[2,4-dioxatricyclo[7.3.1.05,13]trideca-1(12),5,7,9(13),10-pentaene-3,8'-3,4,6,7-tetrahydro-2H-naphthalene]-1'-one
SMILES
C1[C@@H]([C@@H](C2=C[C@@H]([C@H](C3([C@@]2(C1=O)O)OC4=CC=CC5=C4C(=CC=C5)O3)O)O)O)O
InChI
InChI=1S/C20H18O8/c21-11-8-15(23)19(26)10(17(11)24)7-12(22)18(25)20(19)27-13-5-1-3-9-4-2-6-14(28-20)16(9)13/h1-7,11-12,17-18,21-22,24-26H,8H2/t11-,12-,17+,18+,19+/m0/s1
InChIKey
QUYXDKPCDHWNLZ-OHUKFJGISA-N
Synonyms
Palmarumycin B5; CHEMBL3342636
CAS NA
PubChem CID 101888373
ChEMBL ID CHEMBL3342636
*Note: the IUPAC Name was collected from PubChem.
Chemical Classification:
  • Kingdom: Organic compounds
    • Superclass: Benzenoids
      • Class: Naphthalenes
        • Subclass: No Rank at Level Subclass
          • Direct Parent: Naphthalenes

ClassyFire Version 1.0
PMID:27867422

NPs Species Source

Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference
Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference

NPs Content

*Note: The vaules in Content Percentage are calculated by dividing the content value by the maximum content value in NP Content.
**Note: The units with different NP content, due to their incomparable values, are separated into different tables.

NPs Biological Activity

Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name
Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name

NPs Physi-Chem Properties

Molecular Weight: 386.4 ALogp: -1.2
HBD: 5 HBA: 8
Rotatable Bonds: 0 Lipinski's rule of five: Accepted
Polar Surface Area: 137.0 Aromatic Rings: 5
Heavy Atoms: 28 QED Weighted: 0.394

NPs ADMET Properties*

ADMET: Absorption

Caco-2 Permeability: -5.663 MDCK Permeability: 0.00001170
Pgp-inhibitor: 0.009 Pgp-substrate: 0.993
Human Intestinal Absorption (HIA): 0.748 20% Bioavailability (F20%): 0.944
30% Bioavailability (F30%): 0.96

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB): 0.286 Plasma Protein Binding (PPB): 80.47%
Volume Distribution (VD): 0.986 Fu: 12.33%

ADMET: Metabolism

CYP1A2-inhibitor: 0.061 CYP1A2-substrate: 0.092
CYP2C19-inhibitor: 0.02 CYP2C19-substrate: 0.638
CYP2C9-inhibitor: 0.011 CYP2C9-substrate: 0.311
CYP2D6-inhibitor: 0.003 CYP2D6-substrate: 0.121
CYP3A4-inhibitor: 0.02 CYP3A4-substrate: 0.215

ADMET: Excretion

Clearance (CL): 2.212 Half-life (T1/2): 0.432

ADMET: Toxicity

hERG Blockers: 0.021 Human Hepatotoxicity (H-HT): 0.943
Drug-inuced Liver Injury (DILI): 0.933 AMES Toxicity: 0.588
Rat Oral Acute Toxicity: 0.726 Maximum Recommended Daily Dose: 0.37
Skin Sensitization: 0.094 Carcinogencity: 0.722
Eye Corrosion: 0.003 Eye Irritation: 0.016
Respiratory Toxicity: 0.811
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.

Similar Compounds*

Compounds similar to EMNPD with top10 similarity:

Similar NPs Similar Drugs
NPs ID NPs 2D Structure Similarity Score TTD ID Drug 2D Structure Similarity Score
ENC003239 0.580 D0Q3VE 0.246
ENC002330 0.580 D08CCE 0.243
ENC003195 0.570 D06TJJ 0.240
ENC003194 0.554 D0AZ8C 0.239
ENC003197 0.524 D00JRA 0.225
ENC003196 0.524 D06ALD 0.221
ENC003238 0.505 D01TNW 0.219
ENC001999 0.500 D05MQK 0.218
ENC003287 0.500 D09LDR 0.216
ENC003288 0.500 D08DFX 0.213
*Note: the compound similarity was calculated by RDKIT.